secwatch.observer — SEC 8-K summary
======================================

Issuer:     CRISPR Therapeutics AG (CRSP)
CIK:        0001674416
Form:       8-K
Filed at:   2023-06-09T23:59:59+00:00
Accession:  0000950170-23-027277
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CRISPR Therapeutics shareholders approve 1.7M share increase to stock plan, capital band, board reduction
--------------------------------------------------------------------------------

- Shareholders approved amendment to 2018 Stock Plan increasing share reserve by 1.7M shares (including incentive stock options).
- Capital band introduced, authorizing Board to increase share capital until June 8, 2028, replacing authorized capital.
- Maximum Board size reduced; articles amended to comply with revised Swiss corporate law.
- Compensation votes saw significant opposition: equity grants for exec committee had 14.1M votes against (34% of votes cast excluding broker non-votes).
- Proposal to allow Board to handle other business was rejected by shareholders (23.9M against vs 17.5M for).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1674416/000095017023027277/0000950170-23-027277-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1674416/000095017023027277/crsp-20230608.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-027277

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer